Endemic and Epidemic Human Alphavirus Infections in Eastern Panama: An Analysis of Population-Based Cross-Sectional Surveys.
Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Alphavirus
/ immunology
Alphavirus Infections
/ epidemiology
Animals
Antibodies, Viral
/ immunology
Chikungunya Fever
/ epidemiology
Chikungunya virus
/ immunology
Child
Child, Preschool
Cross-Sectional Studies
Depression
/ physiopathology
Dizziness
/ physiopathology
Encephalitis Virus, Eastern Equine
/ immunology
Encephalitis Virus, Venezuelan Equine
/ immunology
Encephalomyelitis, Eastern Equine
/ epidemiology
Encephalomyelitis, Venezuelan Equine
/ epidemiology
Endemic Diseases
Epidemics
Farmers
/ statistics & numerical data
Fatigue
/ physiopathology
Female
Housing
/ statistics & numerical data
Humans
Immunoglobulin G
Immunoglobulin M
Male
Middle Aged
Mosquito Vectors
/ virology
Panama
/ epidemiology
Semliki forest virus
/ immunology
Seroepidemiologic Studies
Sleep Initiation and Maintenance Disorders
/ physiopathology
Young Adult
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
31
10
2020
medline:
12
1
2021
entrez:
30
10
2020
Statut:
ppublish
Résumé
Madariaga virus (MADV) has recently been associated with severe human disease in Panama, where the closely related Venezuelan equine encephalitis virus (VEEV) also circulates. In June 2017, a fatal MADV infection was confirmed in a community of Darien Province. We conducted a cross-sectional outbreak investigation with human and mosquito collections in July 2017, where sera were tested for alphavirus antibodies and viral RNA. In addition, by applying a catalytic, force-of-infection (FOI) statistical model to two serosurveys from Darien Province in 2012 and 2017, we investigated whether endemic or epidemic alphavirus transmission occurred historically. In 2017, MADV and VEEV IgM seroprevalences were 1.6% and 4.4%, respectively; IgG antibody prevalences were MADV: 13.2%, VEEV: 16.8%, Una virus (UNAV): 16.0%, and Mayaro virus: 1.1%. Active viral circulation was not detected. Evidence of MADV and UNAV infection was found near households, raising questions about its vectors and enzootic transmission cycles. Insomnia was associated with MADV and VEEV infections, depression symptoms were associated with MADV, and dizziness with VEEV and UNAV. Force-of-infection analyses suggest endemic alphavirus transmission historically, with recent increased human exposure to MADV and VEEV in Aruza and Mercadeo, respectively. The lack of additional neurological cases suggests that severe MADV and VEEV infections occur only rarely. Our results indicate that over the past five decades, alphavirus infections have occurred at low levels in eastern Panama, but that MADV and VEEV infections have recently increased-potentially during the past decade. Endemic infections and outbreaks of MADV and VEEV appear to differ spatially in some locations of eastern Panama.
Identifiants
pubmed: 33124532
doi: 10.4269/ajtmh.20-0408
pmc: PMC7695115
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2429-2437Subventions
Organisme : FIC NIH HHS
ID : D43 TW007393
Pays : United States
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024855/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R24 AI120942
Pays : United States
Références
Brain Inj. 2002 Oct;16(10):917-27
pubmed: 12419004
J Med Entomol. 2017 Jul 1;54(4):812-820
pubmed: 28402498
Rev Inst Med Trop Sao Paulo. 2003 Mar-Apr;45(2):109-10
pubmed: 12754579
N Engl J Med. 2013 Aug 22;369(8):732-44
pubmed: 23964935
Clin Vaccine Immunol. 2011 Sep;18(9):1486-91
pubmed: 21752946
J Infect Dis. 2016 Feb 15;213(4):604-10
pubmed: 26410592
PLoS Negl Trop Dis. 2016 Apr 21;10(4):e0004554
pubmed: 27101567
Am J Trop Med Hyg. 1965 Nov;14(6):1073-8
pubmed: 5840639
Emerg Infect Dis. 2015 Oct;21(10):1742-50
pubmed: 26401714
Am J Epidemiol. 2003 Feb 15;157(4):364-75
pubmed: 12578807
Sci Rep. 2017 Aug 3;7(1):7248
pubmed: 28775261
Future Virol. 2011;6(6):721-740
pubmed: 21765860
Emerg Infect Dis. 2016 Nov;22(11):2000-2002
pubmed: 27767924
Am J Trop Med Hyg. 2018 Jun;98(6):1798-1804
pubmed: 29737271
Am J Trop Med Hyg. 1984 May;33(3):483-91
pubmed: 6145366
Lancet. 1996 Aug 17;348(9025):436-40
pubmed: 8709783
J Virol. 2010 Jan;84(2):1014-25
pubmed: 19889755
Clin Infect Dis. 2007 Jun 1;44(11):1401-7
pubmed: 17479933
Vector Borne Zoonotic Dis. 2018 May;18(5):266-272
pubmed: 29652644
J Virol Methods. 2001 Jun;95(1-2):153-61
pubmed: 11377722
Trans R Soc Trop Med Hyg. 2007 Oct;101(10):1039-41
pubmed: 17658571
Emerg Infect Dis. 2003 Jan;9(1):49-54
pubmed: 12533281
Am J Trop Med Hyg. 2006 Sep;75(3):461-9
pubmed: 16968922
Am J Trop Med Hyg. 1966 May;15(3):385-400
pubmed: 4380043
Am J Trop Med Hyg. 2007 Feb;76(2):293-8
pubmed: 17297038
J Virol. 2005 Jul;79(14):9128-33
pubmed: 15994807